Cronos Group Inc (NASDAQ:CRON)
2.5 USD
+0.020 0.807%Previous Close (in USD) | 2.48 |
---|---|
Change | +0.020 0.807% |
52 W H/L (in USD) | 2.640/1.640 |
EBITDA (in USD) | -92.394M |
PE Ratio | -- |
Volume | 1405371 |
Diluted Eps TTM | -0.31 |
Total Assets (in USD) | 1213.009M |
---|---|
Total Liabilities (in USD) | 72.045M |
Revenue TTM (in USD) | 90.514M |
Cash (in USD) | 764.644M |
Market Cap (in USD) | 758.417 M |
Revenue Per Share TTM | 0.238 |
Gross Profit TTM (in USD) | 11.969M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Cronos Group Inc
Employees: 447
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Mr. Michael Ryan Gorenstein J.D. | Pres, CEO & Chairman | 1987 |
2. | Ms. Shannon Buggy | Sr. VP & Global Head of People | 1970 |
3. | Ms. Anna Shlimak | Sr. VP of Corp. Affairs & Strategy | 1986 |
4. | Mr. James Holm | Chief Financial Officer | NA |
5. | Mr. Carlos Cortez | VP, Controller & Principal Accounting Officer | 1973 |
6. | Mr. Shayne J. Laidlaw | Director of Investor Relations & Strategy | NA |
7. | Mr. Terry Gregory-Joseph Doucet | Sr. VP of Legal & Regulatory Affairs and Corp. Sec. | 1990 |
8. | Mr. Jeffrey David Jacobson | Chief Growth Officer | 1986 |
9. | Mr. Arye Weigensberg | Head of R&D | NA |
10. | Mr. Kevin B Gifford | VP of Fin. | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
ZTS
Zoetis Inc |
+2.480 1.644% | 150.97 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
MKKGY
Merck KGaA ADR |
-0.370 1.141% | 31.77 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
+6.967 4.399% | 154.8 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
TAK
Takeda Pharmaceutical Co Ltd ADR |
-0.160 1.209% | 13.15 | 32.670 | 11.534 | 0.011 | 0.874 | 0.018 | 0.069 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | -134.559M | -397.135M | -73.273M | 1165.574M | -13.741M |
Minority Interest | 0M | -1.097M | -2.133M | -0.853M | 0.1M |
Net Income | -168.734M | -396.704M | -74.62M | 2455.376M | -13.928M |
Selling General Administrative | 86.293M | 106.633M | 95.89M | 60.991M | 15.902M |
Gross Profit | 11.969M | -17.534M | -25.833M | -17.864M | 8.273M |
Reconciled Depreciation | 13.122M | 15.402M | 7.045M | 3.913M | 1.843M |
Ebit | -116.012M | 6.785M | -179.347M | -121.484M | -13.457M |
Ebitda | -59.185M | 22.187M | -160.085M | -1405.339M | -11.614M |
Depreciation And Amortization | 56.827M | 15.402M | 19.262M | -1283.855M | 1.843M |
Operating Income | -116.012M | 6.785M | -179.347M | -121.484M | -13.295M |
Other Operating Expenses | 207.916M | 271.354M | 226.066M | 139.906M | 24.824M |
Interest Expense | 22.537M | 0.027M | 0.186M | 27.982M | 0.079M |
Tax Provision | 34.175M | -0.431M | 1.347M | 0M | 0.359M |
Interest Income | 22.537M | 9.098M | 18.601M | 1271.528M | 0.476M |
Net Interest Income | 22.537M | 9.071M | 18.375M | -4.226M | 0.079M |
Income Tax Expense | 34.175M | -0.431M | 1.347M | -1289.802M | 0.359M |
Total Revenue | 91.904M | 74.435M | 46.719M | 23.75M | 11.529M |
Total Operating Expenses | 127.981M | 179.385M | 153.514M | 98.292M | 21.568M |
Cost Of Revenue | 79.935M | 91.969M | 72.552M | 41.614M | 3.256M |
Total Other Income Expense Net | -18.547M | -403.92M | 106.074M | 1287.058M | -0.525M |
Net Income From Continuing Ops | -168.734M | -396.704M | -74.62M | 1165.574M | -14.1M |
Net Income Applicable To Common Shares | -168.734M | -396.107M | -73.137M | 1166.506M | -21.636M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Total Assets | 1213.009M | 1397.738M | 1925.682M | 2090.442M | 191.713M |
Intangible Assets | 26.704M | 18.079M | 69.72M | 72.32M | 8.248M |
Other Current Assets | 7.106M | 8.967M | 12.337M | 9.395M | 9.074M |
Total Liab | 72.045M | 63.462M | 217.514M | 341.412M | 36.327M |
Total Stockholder Equity | 1143.885M | 1337.243M | 1711.364M | 1749.883M | 155.286M |
Other Current Liab | 55.623M | 14.375M | 163.41M | 297.16M | 6.615M |
Common Stock | 611.318M | 595.497M | 569.26M | 561.165M | 165.562M |
Capital Stock | 611.318M | 595.497M | 569.26M | 561.165M | 165.562M |
Retained Earnings | 490.682M | 659.416M | 1064.509M | 1137.646M | -16.677M |
Good Will | 1.033M | 1.098M | 179.522M | 214.794M | 1.316M |
Other Assets | 72.538M | 80.735M | 116.669M | 64.404M | 4.689M |
Cash | 764.644M | 886.973M | 1078.023M | 1199.693M | 23.96M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 68.116M | 54.373M | 206.834M | 332.888M | 33.401M |
Current Deferred Revenue | - | 26.069M | - | - | - |
Net Debt | -760.768M | -877.167M | -1068.209M | -1192.586M | -8.578M |
Short Term Debt | 1.33M | 2.711M | 1.322M | 0.427M | 15.382M |
Short Long Term Debt | - | - | - | - | 15.382M |
Short Long Term Debt Total | 3.876M | 9.806M | 9.814M | 7.107M | 15.382M |
Other Stockholder Equity | 42.682M | 32.465M | 34.596M | 23.234M | 5.719M |
Property Plant Equipment | 62.83M | 82.952M | 187.599M | 166.494M | 126.03M |
Total Current Assets | 960.156M | 1079.718M | 1372.172M | 1570.012M | 47.77M |
Long Term Investments | 89.748M | 135.156M | 106.893M | 0.557M | 3.081M |
Short Term Investments | 113.077M | 117.684M | 211.766M | 306.347M | 0M |
Net Receivables | 37.77M | 33.292M | 26.044M | 16.534M | 5.797M |
Long Term Debt | - | - | - | - | 0M |
Inventory | 37.559M | 32.802M | 44.002M | 38.043M | 15.167M |
Accounts Payable | 11.163M | 11.218M | 42.102M | 35.301M | 11.404M |
Accumulated Other Comprehensive Income | -0.797M | 49.865M | 42.999M | 27.838M | 0.683M |
Non Currrent Assets Other | 72.538M | 0.1M | 87.658M | 64.404M | 5.096M |
Non Current Assets Total | 252.853M | 318.02M | 553.51M | 520.43M | 143.943M |
Capital Lease Obligations | 3.876M | 9.806M | 9.814M | 7.107M | 0M |
Long Term Debt Total | - | - | - | - | 0M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | -1.842M | -14.699M | 50.752M | -359.905M | -5.091M |
Total Cashflows From Investing Activities | -1.842M | -28.898M | 20.15M | -603.539M | -93.908M |
Total Cash From Financing Activities | -2.897M | -13.442M | -5.465M | 1856.941M | 113.536M |
Net Income | -168.734M | -397.204M | -75.27M | 1165.574M | -14.1M |
Change In Cash | -122.329M | -191.05M | -121.67M | 1175.766M | 17.199M |
Begin Period Cash Flow | 886.973M | 1078.023M | 1199.693M | 23.927M | 6.76M |
End Period Cash Flow | 764.644M | 886.973M | 1078.023M | 1199.693M | 23.96M |
Total Cash From Operating Activities | -88.948M | -153.616M | -142.457M | -130.007M | -7.15M |
Depreciation | 13.122M | 15.402M | 7.045M | 3.913M | 1.843M |
Other Cashflows From Investing Activities | 0.452M | 1.652M | 0.81M | -204.97M | -0.231M |
Dividends Paid | 0.384M | - | - | - | 0M |
Change To Inventory | -7.217M | 11.565M | -28.094M | 29.44M | -3.892M |
Sale Purchase Of Stock | - | - | -1.019M | 1805.834M | 118.122M |
Other Cashflows From Financing Activities | -2.513M | -13.442M | -3.051M | 1922.14M | 6.32M |
Capital Expenditures | 5.032M | 12.262M | 35.391M | 38.953M | 84.262M |
Change In Working Capital | 20.663M | -2.005M | -33.943M | -54.208M | 3.483M |
Other Non Cash Items | 30.886M | -2.179M | -56.997M | 4.627M | -1.847M |
Free Cash Flow | -93.98M | -165.878M | -177.848M | -168.96M | -91.412M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | ETFMG Alternative Harvest ETF | 4 months ago | 5399750 |
2. | Horizons Marijuana Life Sciences ETF | 4 months ago | 4179302 |
3. | Vanguard Total Intl Stock Index Inv | 4 months ago | 2577810 |
4. | Vanguard Developed Markets Index Admiral | 4 months ago | 1626883 |
5. | Vanguard Instl Ttl Intl Stk Mkt Idx TrII | 4 months ago | 1297586 |
6. | Vanguard FTSE All-Wld ex-US SmCp Idx Ins | 4 months ago | 709666 |
7. | Global X Cannabis ETF | 4 months ago | 693793 |
8. | Dimensional Canadian Small Company | 8 months ago | 645729 |
9. | DFA International Small Company I | 5 months ago | 636746 |
10. | Amplify Seymour Cannabis ETF | 4 months ago | 595463 |
11. | AdvisorShares Pure Cannabis ETF | 4 months ago | 500000 |
12. | USA Mutuals Vice Investor | 6 months ago | 480000 |
13. | DFA International Core Equity I | 5 months ago | 440663 |
14. | State St Gbl Sm Cp Eq ex-US Indx NL Cl A | 4 months ago | 425101 |
15. | DFA Canadian Core Equity Class F | 6 months ago | 417320 |
16. | Vanguard FTSE Canada All Cap ETF | 4 months ago | 407808 |
17. | Schwab International Small-Cap Eq ETF™ | 4 months ago | 385980 |
18. | iShares Core MSCI Total Intl Stk ETF | 4 months ago | 373350 |
19. | iShares Core MSCI Intl Dev Mkts ETF | 4 months ago | 274969 |
20. | Fidelity Nasdaq Composite Index | 5 months ago | 260717 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Chescapmanager LLC | 6 months ago | 8327090 |
2. | Vanguard Group Inc | 6 months ago | 6953360 |
3. | Dimensional Fund Advisors, Inc. | 6 months ago | 1758091 |
4. | Intact Investment Management, Inc. | 6 months ago | 1108300 |
5. | Millennium Management LLC | 6 months ago | 994641 |
6. | Mirae Asset Global Investments (Korea) Co Ltd | 6 months ago | 866167 |
7. | D. E. Shaw & Co LP | 6 months ago | 777888 |
8. | Kerrisdale Advisers, LLC | 6 months ago | 724202 |
9. | Susquehanna International Group, LLP | 6 months ago | 596257 |
10. | Penserra Capital Management, LLC | 6 months ago | 595463 |
11. | Swiss National Bank | 6 months ago | 453100 |
12. | AXS Investments LLC | 6 months ago | 424125 |
13. | Group One Trading, LP | 6 months ago | 384143 |
14. | Goldman Sachs Group Inc | 6 months ago | 360663 |
15. | Morgan Stanley - Brokerage Accounts | 6 months ago | 325130 |
16. | JANE STREET GROUP, LLC | 6 months ago | 290561 |
17. | Citadel Advisors Llc | 6 months ago | 284519 |
18. | Geode Capital Management, LLC | 6 months ago | 260717 |
19. | Clarivest Asset Management LLC | 6 months ago | 258855 |
20. | Credit Suisse First Boston (CSFB) | 6 months ago | 237135 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).